Vector Science & Therapeutics Corp. Grants Options as Company Advances Growth Strategy
MEQUON, Wis., June 2, 2026 /PRNewswire/ -- Vector Science & Therapeutics (TSXV: PAIN) ("Vector" or the "Company") today announced that the Board of Directors has approved the grant of 206,610 stock options (the "Options") to certain directors of the Company in accordance with the...
MEQUON, Wis., June 2, 2026 /PRNewswire/ -- Vector Science & Therapeutics (TSXV: PAIN) ("Vector" or the "Company") today announced that the Board of Directors has approved the grant of 206,610 stock options (the "Options") to certain directors of the Company in accordance with the...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.